Sardido, Baby Girl .
HRN: 23-95-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/29/2023
11/05/2023
IV
30
Q24
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes